IDiyas

For the Inventor, By the Inventor

Lexington, MA, United States of America

Concert Pharmaceuticals, Inc.


USPTO Granted Patents = 136



Trademarks = 2

Forward Citations = 1,279


where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents


39 inventors (with patents filed for the assignee):

goldMedal Roger D Tung (74 out of 126 patents)

silverMedal Scott L Harbeson (47 out of 60 patents)

bronzeMedal Julie Fields Liu (36 out of 41 patents)

4.  Craig E Masse (17 out of 72 patents)

5.  I Robert Silverman (11 out of 14 patents)

6.  Adam J Morgan (9 out of 13 patents)

7.  Philip B Graham (9 out of 9 patents)

8.  Rose A Persichetti (5 out of 6 patents)

9.  Bhaumik Pandya (4 out of 12 patents)

10.  Emerich Eisenreich (2 out of 5 patents)

11.  Xuejun Karl Liu (2 out of 5 patents)

12.  Robert Silverman (2 out of 2 patents)

13.  Ian Robert Silverman (2 out of 2 patents)

14.  Xuejun Tang (2 out of 3 patents)

15.  Andrew D Jones (2 out of 12 patents)


136 patents:

1. 12319954 - Morphinan compounds (2025-06-03),
2. 11473123 - Morphinan compounds (2022-10-18),
3. 11267777 - Deuterated EPI-743 (2022-03-08),
4. 11161798 - 4-hydroxybutyric acid analogs (2021-11-02),
5. 10843993 - Deuterated idebenone (2020-11-24),
6. 10842792 - Deuterated baricitinib (2020-11-24),
7. 10813926 - Morphinan compounds (2020-10-27),
8. 10683305 - Deuterated OTX-015 (2020-06-16),
9. 10668036 - Deuterated analogs of D-serine and uses thereof (2020-06-02),
10. 10561659 - Treatment of hair loss disorders with deuterated JAK inhibitors (2020-02-18),
11. 10532971 - 4-hydroxybutyric acid analogs (2020-01-14),
12. 10442761 - Deuterated GFT-505 (2019-10-15),
13. 10406155 - Morphinan compounds (2019-09-10),
14. 10385042 - Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase (2019-08-20),
15. 10357499 - Substituted triazolobenzodiazepines (2019-07-23),
Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for patients with serious diseases. With a proprietary deuterium chemistry approach, Concert aims to optimize existing drugs and create new chemical entities with enhanced therapeutic benefits. By leveraging its expertise in drug design, Concert is committed to improving the lives of patients through the development of novel medicines.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

...
136 Patents

#7 in Lexington, MA

#148 in Massachusetts

#2,738 in US

#5,761 in the World

...
Lexington, MA, United States of America

Concert Pharmaceuticals, Inc.

Forward Citations = 1,279

39 inventors:

goldMedal Roger D Tung (74 out of 126 patents)

silverMedal Scott L Harbeson (47 out of 60 patents)

bronzeMedal Julie Fields Liu (36 out of 41 patents)

4.  Craig E Masse (17 out of 72 patents)

5.  I Robert Silverman (11 out of 14 patents)

Please report any incorrect information to support@idiyas.com
Loading…